Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis CRNX

Max Ratio

Dividend Yield

5Y Dividend Growth

0.00 %

Consecutive Years

5Y Average Payout Ratio

Dividend History CRNX

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth CRNX

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin CRNX

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income CRNX

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM CRNX

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio CRNX

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Crinetics Pharmaceuticals Inc CRNX

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Itself CRNX

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE
Forward PE
Enterprise Value Revenue 392.74
Price Sales TTM 508.15
Enterprise Value EBITDA -13.40
Price Book MRQ 4.03

Crinetics Pharmaceuticals Inc Dividends: Yield, History, Payment Schedule

CRNX
Current price
37.49 USD +0.83 USD (+2.26%)
Last closed 36.51 USD
ISIN US22663K1079
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 3 910 743 808 USD
Yield for 12 month +6.51 %
1Y
3Y
5Y
10Y
15Y
CRNX
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+7 696 000 USD

Last Year

+1 039 000 USD

Current Quarter

+3 885 000 USD

Last Quarter

+143 000 USD

Current Year

+2 730 000 USD

Last Year

+1 039 000 USD

Current Quarter

+4 344 000 USD

Last Quarter

+143 000 USD
EBITDA -512 879 008 USD
Operating Margin TTM -2 169.55 %
Price to Earnings
Return On Assets TTM -25.22 %
PEG Ratio
Return On Equity TTM -40.17 %
Wall Street Target Price 83.50 USD
Revenue TTM 7 696 000 USD
Book Value 10.38 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 158.40 %
Dividend Yield
Gross Profit TTM -325 438 016 USD
Earnings per share -4.95 USD
Diluted Eps TTM -4.95 USD
Most Recent Quarter IV 2025
Quarterly Earnings Growth YOY
Profit Margin
Price to Free Cash Flow TTM -10.23

Technical Indicators CRNX

For 52 Weeks

24.10 USD 57.99 USD
50 Day MA 47.49 USD
Shares Short Prior Month 14 453 914
200 Day MA 39.43 USD
Short Ratio 14.29
Shares Short 14 158 444
Short Percent 15.86 %